Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the World Health Organization International System for Reporting Pancreatic Cytopathology.
Sana Ahuja, Marzieh Fattahi-Darghlou, Rhea Ahuja, Apoorva Kabra, Sufian Zaheer
{"title":"Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the World Health Organization International System for Reporting Pancreatic Cytopathology.","authors":"Sana Ahuja, Marzieh Fattahi-Darghlou, Rhea Ahuja, Apoorva Kabra, Sufian Zaheer","doi":"10.1159/000547624","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The World Health Organization (WHO), in collaboration with the International Academy of Cytology and the International Agency for Research on Cancer, has introduced a standardized reporting system for pancreatic cytopathology. This system refines diagnostic categories, integrates malignancy risk estimates, and aligns with the WHO Classification of Tumours. It builds on the Papanicolaou Society of Cytopathology framework, improving risk stratification through categories such as pancreatic neoplasm low risk/grade (PaN-Low) and pancreatic neoplasm high risk/grade (PaN-High). This study evaluates the diagnostic accuracy of fine-needle aspiration biopsy (FNAB) for pancreatic lesions using the WHO system.</p><p><strong>Methods: </strong>A systematic literature search was performed in the PubMed and EMBASE databases, using predefined keywords: \"pancreas\", \"FNAB\", and \"diagnostic accuracy\". Meta-analysis was conducted to determine sensitivity and specificity at different diagnostic thresholds: \"PaN-High considered positive,\" \"suspicious for malignancy considered positive,\" and \"malignant considered positive,\" excluding inadequate samples from each study. To assess diagnostic accuracy, summary receiver operating characteristic curves were generated, and the diagnostic odds ratio (DOR) was pooled.</p><p><strong>Results: </strong>Five studies met the inclusion criteria. The risk of malignancy ranged from 3% (negative) to 99% (malignant). Sensitivity and specificity varied across cutoffs: malignant (83%, 100%), suspicious and above (92%, 98%), and PaN-High and above (93%, 96%). DOR values confirmed high diagnostic accuracy.</p><p><strong>Conclusion: </strong>The system effectively stratifies lesions based on malignant potential, with the \"suspicious\" and \"malignant\" categories demonstrating high predictive value. Expanding the diagnostic threshold to include \"PaN-High\" further improves sensitivity without significantly compromising specificity, making it a valuable classification for clinical practice.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-17"},"PeriodicalIF":1.7000,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Cytologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547624","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The World Health Organization (WHO), in collaboration with the International Academy of Cytology and the International Agency for Research on Cancer, has introduced a standardized reporting system for pancreatic cytopathology. This system refines diagnostic categories, integrates malignancy risk estimates, and aligns with the WHO Classification of Tumours. It builds on the Papanicolaou Society of Cytopathology framework, improving risk stratification through categories such as pancreatic neoplasm low risk/grade (PaN-Low) and pancreatic neoplasm high risk/grade (PaN-High). This study evaluates the diagnostic accuracy of fine-needle aspiration biopsy (FNAB) for pancreatic lesions using the WHO system.
Methods: A systematic literature search was performed in the PubMed and EMBASE databases, using predefined keywords: "pancreas", "FNAB", and "diagnostic accuracy". Meta-analysis was conducted to determine sensitivity and specificity at different diagnostic thresholds: "PaN-High considered positive," "suspicious for malignancy considered positive," and "malignant considered positive," excluding inadequate samples from each study. To assess diagnostic accuracy, summary receiver operating characteristic curves were generated, and the diagnostic odds ratio (DOR) was pooled.
Results: Five studies met the inclusion criteria. The risk of malignancy ranged from 3% (negative) to 99% (malignant). Sensitivity and specificity varied across cutoffs: malignant (83%, 100%), suspicious and above (92%, 98%), and PaN-High and above (93%, 96%). DOR values confirmed high diagnostic accuracy.
Conclusion: The system effectively stratifies lesions based on malignant potential, with the "suspicious" and "malignant" categories demonstrating high predictive value. Expanding the diagnostic threshold to include "PaN-High" further improves sensitivity without significantly compromising specificity, making it a valuable classification for clinical practice.
期刊介绍:
With articles offering an excellent balance between clinical cytology and cytopathology, ''Acta Cytologica'' fosters the understanding of the pathogenetic mechanisms behind cytomorphology and thus facilitates the translation of frontline research into clinical practice. As the official journal of the International Academy of Cytology and affiliated to over 50 national cytology societies around the world, ''Acta Cytologica'' evaluates new and existing diagnostic applications of scientific advances as well as their clinical correlations. Original papers, review articles, meta-analyses, novel insights from clinical practice, and letters to the editor cover topics from diagnostic cytopathology, gynecologic and non-gynecologic cytopathology to fine needle aspiration, molecular techniques and their diagnostic applications. As the perfect reference for practical use, ''Acta Cytologica'' addresses a multidisciplinary audience practicing clinical cytopathology, cell biology, oncology, interventional radiology, otorhinolaryngology, gastroenterology, urology, pulmonology and preventive medicine.